Through IHC staining, we found that KMT2D was significantly downregulated in PDAC tissues (Figure 3A,B), and negatively correlated with tumor stage, lymph node metastasis, and distal metastasis in PDAC patients (Figure 3C–E). The gene discussed is KMT2D; the disease is neoplasm.